, Tracking Stock Market Picks
Enter Symbol:
Cooper Companies, Inc. (the) (COO) [hlAlert]

up 143.90 %

Cooper Companies, Inc. (the) (COO) rated Outperform by William Blair

Posted on: Thursday,  Aug 11, 2011  12:25 PM ET by William Blair

William Blair rated Outperform Cooper Companies, Inc. (NYSE: COO) on 08/11/2011, when the stock price was $67.32.
Since then, Cooper Companies, Inc. has gained 143.91% as of 01/27/2016's recent price of $164.20.
If you would have followed this William Blair's recommendation on COO, you would have gained 143.9% of your investment in 1630 days.

The Cooper Companies, Inc. (Cooper) develops, manufactures and markets healthcare products, primarily medical devices, through its two business units: CooperVision, Inc. (CVI) and CooperSurgical, Inc. (CSI). CVI develops, manufactures and markets a range of contact lenses for the worldwide vision correction market. CSI develops, manufactures and markets medical devices, diagnostic products, and surgical instruments and accessories used primarily by gynecologists and obstetricians. On February 22, 2007, CSI acquired Wallach Surgical Devices, Inc. Wallach?s products consist of various diagnostic and therapeutic medical instruments primarily for in-office use in women?s healthcare and other specialty instruments relating to dermatology, ophthalmology, anesthesiology, dentistry and veterinary medicine.

The Equity Research department provides the firm's clients with in-depth investment analysis and investment recommendations. Acting as the company's laboratory for new investment ideas, it specializes in providing investment analysis on quality growth companies. Located together in our Chicago office, our equity analysts currently follow a universe of nearly 360 companies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/11/2011 12:25 PM Buy
as of 12/30/2011
1 Week up  0.44 %
1 Month up  15.11 %
3 Months down  -10.90 %
1 YTD up  4.75 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy